Partnering for success: Choosing the right CDMO in pharma outsourcing

Contract development and manufacturing organizations (CDMOs) have become an integral part of the pharmaceutical industry. Companies appreciate the many benefits of outsourcing, including greater flexibility, increased resources and capital for strategic initiatives, and access to specialist expertise and experience. However, amid intense competition and movement by some companies to consolidate operations, pharma leaders are re-examining the role of CDMOs.

It’s smart to stop and question the status quo. It’s also best to respond proactively, not reactively, to shifts in the business world. Now more than ever, sponsors are set on choosing a dependable outsourcing partner with these four qualities: Stability, Quality, Forward thinking and Strategic alignment.